These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35100239)
1. Clascoterone cream (Winlevi) for acne. Med Lett Drugs Ther; 2021 Dec; 63(1640):202-204. PubMed ID: 35100239 [No Abstract] [Full Text] [Related]
2. Drugs for acne. Med Lett Drugs Ther; 2024 Feb; 66(1695):17-20. PubMed ID: 38294764 [No Abstract] [Full Text] [Related]
3. Drugs for acne. Med Lett Drugs Ther; 2020 Nov; 62(1612):188-191. PubMed ID: 33443492 [No Abstract] [Full Text] [Related]
4. Trifarotene (Aklief) - a new topical retinoid for acne. Med Lett Drugs Ther; 2019 Dec; 61(1587):195-197. PubMed ID: 31999666 [No Abstract] [Full Text] [Related]
5. Guidelines of care for the management of acne vulgaris. Reynolds RV; Yeung H; Cheng CE; Cook-Bolden F; Desai SR; Druby KM; Freeman EE; Keri JE; Stein Gold LF; Tan JKL; Tollefson MM; Weiss JS; Wu PA; Zaenglein AL; Han JM; Barbieri JS J Am Acad Dermatol; 2024 May; 90(5):1006.e1-1006.e30. PubMed ID: 38300170 [TBL] [Abstract][Full Text] [Related]
6. Minocycline foam (Amzeeq) for acne. Med Lett Drugs Ther; 2020 May; 62(1597):68-70. PubMed ID: 32555112 [No Abstract] [Full Text] [Related]
7. Cabtreo: A three-drug gel for acne. Med Lett Drugs Ther; 2024 Apr; 66(1700):59-60. PubMed ID: 38576148 [No Abstract] [Full Text] [Related]
8. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older. Gold M Expert Rev Clin Immunol; 2021 Apr; 17(4):301-308. PubMed ID: 33616473 [TBL] [Abstract][Full Text] [Related]
9. Clascoterone (Winlevi) for the Treatment of Acne. Harris C Am Fam Physician; 2021 Jul; 104(1):93-94. PubMed ID: 34264597 [No Abstract] [Full Text] [Related]
10. Clascoterone: a new topical anti-androgen for acne management. Santhosh P; George M Int J Dermatol; 2021 Dec; 60(12):1561-1565. PubMed ID: 34242398 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study. Mazzetti A; Moro L; Gerloni M; Cartwright M J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549 [TBL] [Abstract][Full Text] [Related]
12. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro. Rosette C; Agan FJ; Mazzetti A; Moro L; Gerloni M J Drugs Dermatol; 2019 May; 18(5):412-418. PubMed ID: 31141847 [TBL] [Abstract][Full Text] [Related]
13. Clascoterone: First Approval. Dhillon S Drugs; 2020 Nov; 80(16):1745-1750. PubMed ID: 33030710 [TBL] [Abstract][Full Text] [Related]
14. Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years. Piszczatoski CR; Powell J Clin Ther; 2021 Oct; 43(10):1638-1644. PubMed ID: 34607697 [TBL] [Abstract][Full Text] [Related]
15. Tretinoin/benzoyl peroxide cream (Twyneo) for acne. Med Lett Drugs Ther; 2022 May; 64(1650):75-76. PubMed ID: 35536121 [No Abstract] [Full Text] [Related]
16. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials. Hebert A; Thiboutot D; Stein Gold L; Cartwright M; Gerloni M; Fragasso E; Mazzetti A JAMA Dermatol; 2020 Jun; 156(6):621-630. PubMed ID: 32320027 [TBL] [Abstract][Full Text] [Related]
17. Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris. Eichenfield L; Hebert A; Gold LS; Cartwright M; Fragasso E; Moro L; Mazzetti A J Am Acad Dermatol; 2020 Aug; 83(2):477-485. PubMed ID: 32348828 [TBL] [Abstract][Full Text] [Related]